Junxia Yan1, Toshiaki Hitomi1, Katsunobu Takenaka1, Masayasu Kato1, Hatasu Kobayashi1, Hiroko Okuda1, Kouji H Harada1, Akio Koizumi2. 1. From the Department of Epidemiology and Health Statistics, School of Public Health, Central South University, Hunan, China (J.Y.); Department of Health and Environmental Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan (J.Y., H.K., H.O., T.H., K.H.H, A.K.); and Department of Neurosurgery, Takayama Red Cross Hospital, Takayama, Japan (K.T., M.K.). 2. From the Department of Epidemiology and Health Statistics, School of Public Health, Central South University, Hunan, China (J.Y.); Department of Health and Environmental Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan (J.Y., H.K., H.O., T.H., K.H.H, A.K.); and Department of Neurosurgery, Takayama Red Cross Hospital, Takayama, Japan (K.T., M.K.). koizumi.akio.5v@kyoto-u.ac.jp.
Abstract
BACKGROUND AND PURPOSE: Rupture of intracranial aneurysms (IAs) causes subarachnoid hemorrhage, leading to immediate death or severe disability. Identification of the genetic factors involved is critical for disease prevention and treatment. We aimed to identify the susceptibility genes for IAs. METHODS: Exome sequencing was performed in 12 families with histories of multiple cases of IA (number of cases per family ≥3), with a total of 42 cases. Various filtering strategies were used to select the candidate variants. Replicate association studies of several candidate variants were performed in probands of 24 additional IA families and 426 sporadic IA cases. Functional analysis for the mutations was conducted. RESULTS: After sequencing and filtering, 78 variants were selected for the following reasons: allele frequencies of variants in 42 patients was significantly (P<0.05) larger than expected; variants were completely shared by all patients with IA within ≥1 family; variants predicted damage to the structure or function of the protein by PolyPhen-2 (Polymorphism Phenotyping V2) and SIFT (Sorting Intolerance From Tolerant). We selected 10 variants from 9 genes (GPR63, ADAMST15, MLL2, IL10RA, PAFAH2, THBD, IL11RA, FILIP1L, and ZNF222) to form 78 candidate variants by considering commonness in families, known disease genes, or ontology association with angiogenesis. Replicate association studies revealed that only p.E133Q in ADAMTS15 was aggregated in the familial IA cases (odds ratio, 5.96; 95% confidence interval, 2.40-14.82; P=0.0001; significant after the Bonferroni correction [P=0.05/78=0.0006]). Silencing ADAMTS15 and overexpression of ADAMTS15 p.E133Q accelerated endothelial cell migration, suggesting that ADAMTS15 may have antiangiogenic activity. CONCLUSIONS: ADAMTS15 is a candidate gene for IAs.
BACKGROUND AND PURPOSE: Rupture of intracranial aneurysms (IAs) causes subarachnoid hemorrhage, leading to immediate death or severe disability. Identification of the genetic factors involved is critical for disease prevention and treatment. We aimed to identify the susceptibility genes for IAs. METHODS: Exome sequencing was performed in 12 families with histories of multiple cases of IA (number of cases per family ≥3), with a total of 42 cases. Various filtering strategies were used to select the candidate variants. Replicate association studies of several candidate variants were performed in probands of 24 additional IA families and 426 sporadic IA cases. Functional analysis for the mutations was conducted. RESULTS: After sequencing and filtering, 78 variants were selected for the following reasons: allele frequencies of variants in 42 patients was significantly (P<0.05) larger than expected; variants were completely shared by all patients with IA within ≥1 family; variants predicted damage to the structure or function of the protein by PolyPhen-2 (Polymorphism Phenotyping V2) and SIFT (Sorting Intolerance From Tolerant). We selected 10 variants from 9 genes (GPR63, ADAMST15, MLL2, IL10RA, PAFAH2, THBD, IL11RA, FILIP1L, and ZNF222) to form 78 candidate variants by considering commonness in families, known disease genes, or ontology association with angiogenesis. Replicate association studies revealed that only p.E133Q in ADAMTS15 was aggregated in the familial IA cases (odds ratio, 5.96; 95% confidence interval, 2.40-14.82; P=0.0001; significant after the Bonferroni correction [P=0.05/78=0.0006]). Silencing ADAMTS15 and overexpression of ADAMTS15p.E133Q accelerated endothelial cell migration, suggesting that ADAMTS15 may have antiangiogenic activity. CONCLUSIONS:ADAMTS15 is a candidate gene for IAs.
Authors: Isabel Hernandez; Jessica J Hayward; Jeff A Brockman; Michelle E White; Lara Mouttham; Elizabeth A Wilcox; Susan Garrison; Marta G Castelhano; John P Loftus; Filipe Espinheira Gomes; Cheryl Balkman; Marjory B Brooks; Nadine Fiani; Marnin Forman; Tom Kern; Bruce Kornreich; Eric C Ledbetter; Santiago Peralta; Angela M Struble; Lisa Caligiuri; Elizabeth Corey; Lin Lin; Julie Jordan; Danny Sack; Adam R Boyko; Leslie A Lyons; Rory J Todhunter Journal: Front Vet Sci Date: 2022-06-16
Authors: Mark K Bakker; Suze Cobyte; Frederic A M Hennekam; Gabriel J E Rinkel; Jan H Veldink; Ynte M Ruigrok Journal: Eur J Hum Genet Date: 2022-03-01 Impact factor: 5.351
Authors: Mark K Bakker; Rick A A van der Spek; Wouter van Rheenen; Sandrine Morel; Romain Bourcier; Isabel C Hostettler; Varinder S Alg; Kristel R van Eijk; Masaru Koido; Masato Akiyama; Chikashi Terao; Koichi Matsuda; Robin G Walters; Kuang Lin; Liming Li; Iona Y Millwood; Zhengming Chen; Guy A Rouleau; Sirui Zhou; Kristiina Rannikmäe; Cathie L M Sudlow; Henry Houlden; Leonard H van den Berg; Christian Dina; Olivier Naggara; Jean-Christophe Gentric; Eimad Shotar; François Eugène; Hubert Desal; Bendik S Winsvold; Sigrid Børte; Marianne Bakke Johnsen; Ben M Brumpton; Marie Søfteland Sandvei; Cristen J Willer; Kristian Hveem; John-Anker Zwart; W M Monique Verschuren; Christoph M Friedrich; Sven Hirsch; Sabine Schilling; Jérôme Dauvillier; Olivier Martin; Gregory T Jones; Matthew J Bown; Nerissa U Ko; Helen Kim; Jonathan R I Coleman; Gerome Breen; Jonathan G Zaroff; Catharina J M Klijn; Rainer Malik; Martin Dichgans; Muralidharan Sargurupremraj; Turgut Tatlisumak; Philippe Amouyel; Stéphanie Debette; Gabriel J E Rinkel; Bradford B Worrall; Joanna Pera; Agnieszka Slowik; Emília I Gaál-Paavola; Mika Niemelä; Juha E Jääskeläinen; Mikael von Und Zu Fraunberg; Antti Lindgren; Joseph P Broderick; David J Werring; Daniel Woo; Richard Redon; Philippe Bijlenga; Yoichiro Kamatani; Jan H Veldink; Ynte M Ruigrok Journal: Nat Genet Date: 2020-11-16 Impact factor: 41.307
Authors: Isabel C Hostettler; Benjamin O'Callaghan; Enrico Bugiardini; Emer O'Connor; Jana Vandrovcova; Indran Davagnanam; Varinder Alg; Stephen Bonner; Daniel Walsh; Diederik Bulters; Neil Kitchen; Martin M Brown; Joan Grieve; David J Werring; Henry Houlden Journal: Neurology Date: 2020-10-26 Impact factor: 9.910